Abstract:Multimodal, imaging-genomics techniques offer a platform for understanding genetic influences on brain abnormalities in psychiatric disorders. Such approaches utilize the information available from both imaging and genomics data and identify their association. Particularly for complex disorders such as schizophrenia, the relationship between imaging and genomic features may be better understood by incorporating additional information provided by advanced multimodal modeling. In this study, we propose a novel framework to combine features corresponding to functional magnetic resonance imaging (functional) and single nucleotide polymorphism (SNP) data from 61 schizophrenia (SZ) patients and 87 healthy controls (HC). In particular, the features for the functional and genetic modalities include dynamic (i.e., time-varying) functional network connectivity (dFNC) features and the SNP data, respectively. The dFNC features are estimated from component time-courses, obtained using group independent component analysis (ICA), by computing sliding-window functional network connectivity, and then estimating subject specific states from this dFNC data using a k-means clustering approach. For each subject, both the functional (dFNC states) and SNP data are selected as features for a parallel ICA (pICA) based imaging-genomic framework. This analysis identified a significant association between a SNP component (defined by large clusters of functionally related SNPs statistically correlated with phenotype components) and time-varying or dFNC component (defined by clusters of related connectivity links among distant brain regions distributed across discrete dynamic states, and statistically correlated with genomic components) in schizophrenia. Importantly, the polygenetic risk score (PRS) for SZ (computed as a linearly weighted sum of the genotype profiles with weights derived from the odds ratios of the psychiatric genomics consortium (PGC)) was negatively correlated with the significant dFNC component, which were mostly present within a state that exhibited a lower occupancy rate in individuals with SZ compared with HC, hence identifying a potential dFNC imaging biomarker for schizophrenia. Taken together, the current findings provide preliminary evidence for a link between dFNC measures and genetic risk, suggesting the application of dFNC patterns as biomarkers in imaging genetic association study.

Shaping the Trans-Scale Properties of Schizophrenia via Cerebral Alterations on Magnetic Resonance Imaging and Single-Nucleotide Polymorphisms of Coding and Non-Coding Regions

Multi-scale Analysis of Schizophrenia Risk Genes, Brain Structure, and Clinical Symptoms Reveals Integrative Clues for Subtyping Schizophrenia Patients

Neuroimaging and Multiomics Reveal Cross-Scale Circuit Abnormalities in Schizophrenia

A Schizophrenia-Related Genetic-Brain-Cognition Pathway Revealed in a Large Chinese Population.

Associating Multimodal Neuroimaging Abnormalities with the Transcriptome and Neurotransmitter Signatures in Schizophrenia.

Associations Between Brain Abnormalities and Common Genetic Variants for Schizophrenia: a Narrative Review of Structural and Functional Neuroimaging Findings

Genome-Wide Association Analysis With Gray Matter Volume As A Quantitative Phenotype In First-Episode Treatment-Naive Patients With Schizophrenia

A Framework for Linking Resting-State Chronnectome/genome Features in Schizophrenia: A Pilot Study

An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation

Integrative Omics of Schizophrenia: from Genetic Determinants to Clinical Classification and Risk Prediction

The genetic architecture of schizophrenia: review of large-scale genetic studies

Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives

Genome-wide approaches to schizophrenia

CASCADE TF-MIRNA-MRNA REGULATIONS IDENTIFIED BY CO-EXPRESSION NETWORK MODULES IN BRAINS OF PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER

Transcriptomic and neuroimaging data integration enhances machine learning classification of schizophrenia

Integrating genome-wide association study with regulatory SNP annotation information identified candidate genes and pathways for schizophrenia.

Advances in Molecular Genetics of Schizophrenia

Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis

Brain transcriptional regulatory architecture and schizophrenia etiology converge between East Asian and European ancestral populations

Multifaceted genomic risk for brain function in schizophrenia.

Polygenic Effects of Schizophrenia on Hippocampal Grey Matter Volume and Hippocampus–medial Prefrontal Cortex Functional Connectivity